IRONMAN - A Better Understanding of the Variation in Care and Treatment - Daniel George
December 11, 2017
Daniel George, MD and Director of GU Oncology talks with Alicia Morgans, MD about the IRONMAN initiative. The intent of the project was to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of a minimum of 5,000 men with advanced cancer, including men with mHSPC and M0/M1 CRPC. The goal is to establish a population-based registry and recruit patients across academic and community practices from Australia, Brazil, Canada, Ireland, Sweden, Switzerland, the United Kingdom (UK), and the US.
This cohort study will facilitate a better understanding of the variation in care and treatment of advanced prostate cancer across countries and across academia and community based practices.
Daniel George, MD
Director of GU Oncology, Duke Cancer Institute Professor of Medicine and Surgery, Duke University School of Medicine, Co-Pi, IRONMAN
Alicia Morgans, MD, MPH
Watch: Lorelei Mucci and Philip Kantoff on Outcomes Research and the IRONMAN Project
Watch: International Registry To Improve Outcomes in Men With Advanced Prostate Cancer-IRONMAN- Lorelei Mucci
IRONMAN: An International Registry for Men with Advanced Prostate CancerAn International Registry for Men with Advanced Prostate Cancer
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)